Lilly and Boehringer's Jardiance, trailing AZ's Farxiga in chronic kidney disease, posts early efficacy win
March 16, 2022
Lilly and Boehringer’s Jardiance, trailing AZ’s Farxiga in chronic kidney disease, posts early efficacy win
fkansteiner
Wed, 03/16/2022 – 10:27
Source link